a:head bio
a:head bio AG is a Vienna-based biotech company founded in 2019 that provides drug development services to pharmaceutical and life sciences clients, operating with a small team (11-50 employees) under CEO Oliver Szolar and CSO Josh Bagley.
- Company typePrivate
- Founded2019
- HeadquartersVienna, Austria
- Headcount11–50
- GTM typeB2B
- OfferingServices
a:head bio firmographics
Firmographics- Name
- a:head bio
- Legal name
- a:head bio AG
- Website
- https://aheadbio.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- a:head bio AG is a Vienna-based biotech company founded in 2019 that provides drug development services to pharmaceutical and life sciences clients, operating with a small team (11-50 employees) under CEO Oliver Szolar and CSO Josh Bagley.
- Ownership category
- akta.pro rank
a:head bio industry classification
Industry- Product category
- Drug Development Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
- akta.pro secondary industries
- Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC), Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK)
Keywords
Where a:head bio is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- Austria
- HQ region
- Europe
Markets served
a:head bio business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
a:head bio product offering
Product offeringCore offering
a:head bio AG is a biotech company that delivers drug development services to external clients, applying a unique approach to therapeutic development. The firm operates as a service provider in the pharmaceutical research value chain, leveraging proprietary scientific know-how to support drug discovery and development programs for partners.
Differentiator
Problem solved
Functional benefit
Products and services
- Drug Development Services Drug development services delivered to pharmaceutical and biotechnology clients, applying a unique biotech approach to support therapeutic development programs. The service is targeted at pharma and biotech companies seeking specialized external development expertise.
Companies that use a:head bio
Customer profileIdeal customer profiles1 record
a:head bio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
a:head bio competitors and assessment
Company assessmentBroad incumbents
- AbCellera Biologics: AbCellera is a leading antibody discovery platform that partners with pharma to identify lead candidates from natural immune repertoires. Like a:head bio, it operates in biologics discovery and engineering services for drug developers, though at significantly greater scale.
- Ginkgo Bioworks: Ginkgo operates a synthetic biology platform serving biotech and industrial customers with cell engineering and organism design services. It shares a:head bio's orientation toward engineered biology as a service, though at much larger scale and broader scope.
- Twist Bioscience: Twist provides synthetic DNA and antibody library services that enable biologics discovery and engineering workflows. It is comparable to a:head bio as a platform provider serving biologics developers.
- WuXi Biologics: WuXi Biologics is a global CDMO offering end-to-end biologics development and manufacturing services. It represents the dominant incumbent in biologics services, comparable to a:head bio at the category level but vastly larger in scale and scope.
- Lonza Group: Lonza is a major CDMO providing biologics process development and manufacturing services. Like a:head bio, it serves drug developers in the biologics space, but as a multinational incumbent with comprehensive capabilities.
Direct peers
- Adimab: Adimab provides antibody discovery and engineering services to biopharma, using a proprietary platform for lead identification and optimization. It is directly comparable to a:head bio's antibody/biologics engineering services focus.
Emerging players
- Recursion Pharmaceuticals: Recursion uses AI/ML-driven approaches for drug discovery, intersecting with a:head bio's positioning around "a unique approach" to drug development. It is comparable as a technology-forward drug discovery platform, though more discovery-stage oriented.
- Insitro: Insitro applies machine learning to drug discovery and development, sharing a:head bio's emphasis on computational/AI-enabled approaches in biotech. It is comparable as a tech-forward platform targeting biologics and small molecule discovery.
Regional players
- Hookipa Pharma: Hookipa is a Vienna-based biotech developing immunotherapies using engineered arenavirus platforms. It shares a:head bio's Vienna biotech ecosystem and biologics engineering orientation, providing regional peer insight.
- Valneva: Valneva is an Austria-headquartered biotech focused on vaccines and biologics development. It is comparable to a:head bio as a Vienna-region biotech with biologics capabilities, though focused on vaccines and travel health products.
Market position
Customer concentration
a:head bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
a:head bio leadership team
Management profileNumber of profiles
Profiles2 records
a:head bio funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
a:head bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about a:head bio
What does a:head bio do?
a:head bio AG is a biotech company that delivers drug development services to external clients, applying a unique approach to therapeutic development. The firm operates as a service provider in the pharmaceutical research value chain, leveraging proprietary scientific know-how to support drug discovery and development programs for partners.
When was a:head bio founded?
a:head bio was founded in 2019. It employs 11 to 50 people.
Where is a:head bio based?
a:head bio is headquartered in Vienna, Austria, in the Europe region.
Who are a:head bio's main competitors?
Broad incumbents on record are AbCellera Biologics, Ginkgo Bioworks, Twist Bioscience, WuXi Biologics and Lonza Group. Adimab is listed as a direct peer. Emerging players are Recursion Pharmaceuticals and Insitro. Regional players are Hookipa Pharma and Valneva.
Does a:head bio have an API?
No public API is recorded for a:head bio.
What industry is a:head bio in?
a:head bio's product category is Drug Development Services. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO. Its NAICS code is 541714 and its SIC code is 8731.